Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2023-03-17 00:00:00 ET · period of report 2023-03-15 · accession 0001823239-23-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-17 | 2023-03-15 | MRVI | ORESHACK KURT | GC | A - Grant | — | +38.4K | 62.4K | +160% | — |
| D | 2023-03-17 | 2023-03-15 | MRVI | ORESHACK KURT | GC | A - Grant | $0.00 | +76.5K | 76.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-15 | A | A | 38,386 | — | 62,356 | D | — | — | (F1) Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of March 15, 2024, March 15, 2025, and March 15, 2026, subject to the Reporting Person's continued employment with the Issuer. |
| 2 | Derivative | Employee Stock Options (Right to Buy) | 2023-03-15 | A | A | 76,500 | $0.00 | 76,500 | D | $15.52 · — to 2033-03-15 | 76,500 Class A Common Stock | (F2) Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 1/48th on April 15, 2023 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer. |